Vanderbilt University Sells Microarrays to Management Team | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Microarrays Inc.'s management team and a group of independent investors have purchased the company from Vanderbilt University for an undisclosed amount, the firm announced today.

The new corporate structure will allow Microarrays to "quickly and nimbly" respond to the growing needs of customers, especially in the diagnostics and healthcare markets, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.